Global Bacterial Disease Diagnostics Market Report and Forecast 2024-2032

Bacterial Disease Diagnostics Market Size

The global bacterial disease diagnostics market was valued at USD 3.1 billion in 2023 due to the rising prevalence of bacterial infections across the globe. The market is expected to grow at a CAGR of 7.10% during the forecast period 2024-2032 and attain a market value of USD 5.8 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Bacterial Disease Diagnostics Market Outlook

• The global bacterial disease diagnostics market growth is expected to be driven by the increasing prevalence of bacterial infections.

• According to the World Health Organization, Tuberculosis (TB) affects around 10 million individuals globally and causes around 1.5 million deaths annually, establishing it as the deadliest infectious disease worldwide. The increasing incidence boosts the demand for effective diagnostic alternatives.

• North America is expected to dominate the market with its advanced healthcare infrastructure, and high spending.

Bacterial Disease Diagnostics Market Overview

Bacterial disease diagnostics are used to detect and identify bacterial pathogens in clinical samples to determine the presence and type of infection. Healthcare providers use a variety of methods for precise diagnosis and treatment decisions. The method for diagnosing bacterial diseases includes taking samples from patients and using methods such as bacterial culture, biochemical tests, DNA amplification through PCR, and serological tests for antibodies/antigens. Imaging techniques like X-rays or CT scans have the capability to determine the level of infections in organs such as the lungs.

Bacterial diseases are caused by pathogenic bacteria, which can impact various areas of the body. It includes infections such as respiratory infections such as tuberculosis, gastrointestinal infections like Salmonella, skin infections like Staphylococcus, and sexually transmitted infections such as gonorrhoea. It can vary from slight ailments to serious diseases such as meningitis and septicemia which require immediate medical attention.

Bacterial Disease Diagnostics Market Growth Drivers

Surge in Prevalence of Bacterial Infections Spurs Market Growth

The market growth can be attributed to the growing incidence of illnesses such as tuberculosis, salmonella, staphylococcus, gonorrhoea, bacterial pneumonia, and urinary tract infections. According to the World Health Organization, Tuberculosis (TB) remains one of the most fatal diseases globally, despite being preventable and treatable. Annually, TB affects around 10 million individuals globally and causes around 1.5 million deaths annually, establishing it as the deadliest infectious disease worldwide.

Population growth, urbanization, and antibiotic-resistant bacteria strains are fueling the demand for sophisticated diagnostic tools. Enhancing diagnostic capabilities, such as molecular diagnostics and point-of-care testing, is essential for quickly identifying bacterial pathogens for effective treatment.

Technological Advancements to Boost Global Bacterial Disease Diagnostics Market Demand

Technological progress such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) are driving the market growth. NGS allows thorough examination of bacterial genomes to precisely identify pathogens. PCR particularly identifies bacterial DNA and decreases the time it takes to make a diagnosis. AI and machine learning enhance data analysis for bacterial infections. In December 2022, Stanford Medicine researchers created a new blood test that can effectively differentiate between bacterial and viral infections, adhering to World Health Organization guidelines. In June 2024, a Dutch scientist was nominated as a finalist for the Young Inventors Prize for developing a portable AI-driven testing tool to diagnose bacterial infections. Slow diagnosis of common bacterial infections causes a significant number of deaths globally. The goal is to enhance treatment decisions through rapid AI detection.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Bacterial Disease Diagnostics Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Growing Awareness Around Early Diagnosis

Rising knowledge about bacterial infections is driving the expansion of the bacterial disease diagnostics market. Efforts to promote public health focus on early identification and prevention, particularly in countries with low to moderate incomes. The public is increasingly concerned due to media attention on outbreaks and antibiotic resistance, leading to a higher need for trustworthy diagnostic tools. Non-profit organizations and health organizations are informing communities about the benefits of diagnostics, leading to a more informed population that actively seeks medical assistance, supporting the progress and use of sophisticated diagnostic techniques.

Government Initiatives and Funding

The government is encouraging collaboration between public and private sectors for the introduction of new products. Financial funding and grants help in the introduction of products to the market, improving diagnostic capabilities and public confidence in healthcare systems.

Impact of COVID-19

The pandemic has had a significant impact on the market. It also emphasises the requirement for advanced testing solutions. The pandemic emphasized the necessity of rapid, accurate, and available diagnostics, transforming bacterial disease detection. Growing focus on infection prevention and prompt identification is driving the need for bacterial examinations.

Demand for Early Diagnosis

Early diagnosis is important for successful management of bacterial infections and for averting potential complications. Enhancements in diagnostic tools make it simpler and enhance patient results. Point-of-care testing tools offer instant outcomes, assisting in quick medical judgments. Further, public health programs aim to increase early detection by raising awareness and implementing screening programs, which drive advancements and funding for bacterial disease testing.

Bacterial Disease Diagnostics Market Segmentation

Market Breakup by Disease 

• Respiratory

• Gastrointestinal

• Genitourinary

• kin and Soft Tissue

• Systemic

• Others

Market Breakup by Product

• Instruments

• Consumables

• Others

Market Breakup by Method

• Culture and Isolation

• Microscopy

• Polymerase Chain Reaction

• Enzyme Linked Immunosorbent Assay

• Biochemical Testing

• Others

Market Breakup by End User

• Hospitals

• Diagnostic Laboratories

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Bacterial Disease Diagnostics Market Share

Segmentation Based on Disease to Witness Substantial Growth

Based on disease, the market is segmented into respiratory, gastrointestinal, genitourinary, skin and soft tissue, systemic, and others. Among them, respiratory disease diagnosis is expected to lead the market.

Respiratory diagnostics are expected to lead due to the widespread presence of diseases such as tuberculosis and pneumonia. These illnesses present a substantial risk to global health, leading to severe sickness and fatalities. The increasing number of respiratory infections in developing countries without access to clean air and healthcare is driving the demand for precise diagnostic methods.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Bacterial Disease Diagnostics Market Analysis by Region

Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to dominate the market with its advanced healthcare infrastructure, high expenditure, and widespread infections. Government efforts and regulations continue to drive market expansion through their backing of healthcare advancements and early detection of diseases.

Europe is also poised to have a significant market share driven by its robust healthcare systems, understanding of bacterial infections, and expanding elderly population. Market growth is boosted by a focus on technology and improved access to healthcare. The market in the Asia-Pacific region is rapidly expanding due to the vast population and rising bacterial infection prevalence. The key factors that are driving the market in this region include an emphasis on early disease detection and improving healthcare infrastructure.

Leading Players in the Bacterial Disease Diagnostics Market

The key features of the market report include patent analysis, grant analysis, funding, and investment analysis as well as strategic initiatives including recent partnerships and collaborations by the leading players. The major companies in the market are as follows:

Cepheid Inc. (a Danaher company)

Cepheid is a division of Danaher Corporation that focuses on automating nucleic acid tests for the detection of pathogens and genetic disorders. It was established in 1996 and has its headquarters in California, United States. In April 2023, the company revealed the plan to launch new tests for infectious diseases like tuberculosis and respiratory viruses.

F. Hoffmann-La Roche Ltd

F. Hoffmann-La Roche also known as Roche is a multinational healthcare company based in Switzerland. It was established in Basel in 1896. The company operates in pharmaceuticals and diagnostics, with a focus on scientific excellence in the discovery and development of medicines and diagnostics.

 Thermo Fisher Scientific Inc. 

Thermo Fisher Scientific Inc. is a US-based corporation focused on life science and clinical research. It provides worldwide analytical tools, clinical research solutions, specialized diagnostic products, lab services, and pharmaceutical and biotech offerings. It was established in 1956 and headquartered in Massachusetts, United States.

Abbott Laboratories

Abbott Laboratories identifies, creates, produces, and markets a wide range of healthcare goods and services. The corporation's offerings consist of medications, supplements, medical tests, and vascular items. It was established in 1888 and having its headquarters in Illinois, USA.

Other players in the market are Becton, Dickinson and Company, bioMerieux, Inc., Bio-Rad Laboratories, Inc., Hologic, Inc., and Siemens Healthineers AG.

Key Highlights of the Report

Key Questions Answered in the Bacterial Disease Diagnostics Market Report

• What was the global bacterial disease diagnostics market value in 2023? 
• What is the global bacterial disease diagnostics market forecast outlook for 2024-2032? 
• What are the regional markets covered in the EMR report?
• What is market segmentation based on disease? 
• What is market segmentation based on product? 
• What is market breakup based on methods?
• What are the major factors aiding the global bacterial disease diagnostics market demand?
• Who are the major end users in the market? 
• How has the market performed so far and how is it anticipated to perform in the coming years? 
• What are the major drivers, opportunities, and restraints in the market?  
• What are the major trends influencing the market?  
• Which regional market is expected to dominate the market share in the forecast period?  
• Which country is likely to experience elevated growth during the forecast period?  
• Who are the key players involved in the global bacterial disease diagnostics market? 
• What are the current unmet needs and challenges in the market? 
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?